Flags

Financial distress

Samil Pharmaceutical

KSC:000520 · KR7000520007

PharmaceuticalsX-Small

360

Value43

Profit price67

Cash yield1

Owner Earnings Yield1

Dividend Yield1

Sales & asset price53

Price/Sales70

EV / Gross Profit33

Price/Book56

Quality44

Returns on capital37

Return on Capital37

Cash Return on Capital38

Return on Equity37

Profit margins39

EBIT Margin25

Gross Profitability52

Cash backing49

Accruals75

Owner Earnings Margin23

Growth56

Sales growth36

Profit growth14

Reinvestment55

Price momentum22

Safety32

Debt load13

Debt serviceability25

Refinancing48

Debt Payback1

Liquidity18

Sentiment50

Analyst ratings100

Expectations trend34

Opinion Changes50

Price Target Upside18

Market mood5

Value Creation0/20not creating value

Creates more value than its capital costs
Owner earnings growing
Owner earnings per share growing
Reinvests at strong returns
Solid earnings base

What this means

Samil Pharmaceutical doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountrySouth Korea

IndustryPharmaceuticals

SizeX-Small

TypePublic Company

ExchangeKOSE

Employees2

Websitesamil-pharm.com

ISINKR7000520007

Last UpdateApr 2, 2026

Indices

KOSPI (South Korea)

Themes

ManufacturingMedicalPharmaceutical

Description

Analysis

Middle-of-the-road

Samil Pharmaceutical Co.,Ltd is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

Valuation data is not available for this company.

The trajectory is moderate and the balance sheet is stretched. The company scores 0/20 on our value-creation score: not creating value.

What to watch: Some accounting patterns deserve a closer look. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250

2026

All-time high

Mar 2026

All-time low

Jun 2026

Average rank

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023

Price/Sales

—

Price/Earnings

—

Price/Book

—

Dividend Yield

—

Value (overall)

—

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Samil Pharmaceutical with its peers

Kukje Pharma

KSC:002720

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Hana Pharm

KSC:293480

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Kyongbo Pharmaceutical

KSC:214390

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Reyon Pharmaceutical

KSC:102460

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Samsung Pharm

KSC:001360

—

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

PharmGen Science

KSC:004720

CountrySouth Korea

IndustryPharmaceuticals

SizeSmall

Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View

1 · Watch OutGood· 100

Value

1 · ExpensiveGood Value· 100

Quality

1 · Weak FundamentalsHigh Quality· 100

Growth

1 · Tough TimesHigh Growth· 100

Safety

1 · High LeverageWell-Financed· 100

Sentiment

1 · SkepticismPositive· 100

Learn More →